Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines
出版年份 2020 全文链接
标题
Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines
作者
关键词
-
出版物
Journal of the American Heart Association
Volume 9, Issue 18, Pages -
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2020-09-05
DOI
10.1161/jaha.120.018403
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
- (2020) G. Curigliano et al. ANNALS OF ONCOLOGY
- Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry
- (2020) José López-Sendón et al. EUROPEAN HEART JOURNAL
- Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis
- (2020) Lili Zhang et al. EUROPEAN HEART JOURNAL
- Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer
- (2020) Charles Dolladille et al. JAMA Oncology
- Identification of anticancer drugs associated with atrial fibrillation - analysis of the WHO pharmacovigilance database
- (2020) Joachim Alexandre et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Ponatinib-induced cardiotoxicity: delineating the signaling mechanisms and potential rescue strategies
- (2019) Anand P Singh et al. CARDIOVASCULAR RESEARCH
- Anticoagulation Strategies in Patients With Cancer
- (2019) Ramya C. Mosarla et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A Consensus Paper by the European Myeloma Network and the Italian Society of Arterial Hypertension
- (2019) Sara Bringhen et al. JOURNAL OF INTERNAL MEDICINE
- Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association
- (2019) Umberto Campia et al. CIRCULATION
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
- (2019) Donna K. Arnett et al. CIRCULATION
- Cardioprotection in cancer therapy: novel insights with anthracyclines
- (2019) Inbar Raber et al. CARDIOVASCULAR RESEARCH
- Cardiovascular toxicities associated with immune checkpoint inhibitors
- (2019) Jiun-Ruey Hu et al. CARDIOVASCULAR RESEARCH
- Anticoagulation of cancer patients with non‐valvular atrial fibrillation receiving chemotherapy: guidance from the SSC of the ISTH
- (2019) A Aurelien Delluc et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Myocarditis in the Setting of Cancer Therapeutics
- (2019) Marc P. Bonaca et al. CIRCULATION
- Takotsubo syndrome in patients with cancer treated with immune checkpoint inhibitors: a new adverse cardiac complication
- (2019) Stephane Ederhy et al. EUROPEAN JOURNAL OF HEART FAILURE
- Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy
- (2019) Khashayar Esfahani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis
- (2019) Joe-Elie Salem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma
- (2019) Robert F. Cornell et al. JOURNAL OF CLINICAL ONCOLOGY
- Real-Life Insight Into Ibrutinib Cardiovascular Events
- (2019) Jutta Bergler-Klein JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Toxicities Associated With Ibrutinib
- (2019) Joe-Elie Salem et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Acute Coronary Syndrome With Immune Checkpoint Inhibitors: A Proof-of-Concept Case and Pharmacovigilance Analysis of a Life-Threatening Adverse Event
- (2019) Jennifer Cautela et al. CANADIAN JOURNAL OF CARDIOLOGY
- Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice
- (2018) John G. Gribben et al. BRITISH JOURNAL OF HAEMATOLOGY
- OUP accepted manuscript
- (2018) EUROPEAN HEART JOURNAL
- Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial
- (2018) Daniela Cardinale et al. EUROPEAN JOURNAL OF CANCER
- Cardiovascular Disease in Survivors of Childhood Cancer: Insights Into Epidemiology, Pathophysiology, and Prevention
- (2018) Saro H. Armenian et al. JOURNAL OF CLINICAL ONCOLOGY
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of Arterial Thrombosis in Cancer Patients
- (2018) Corinne Frere et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Syed S. Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anticancer drug-induced cardiac rhythm disorders: Current knowledge and basic underlying mechanisms
- (2018) Joachim Alexandre et al. PHARMACOLOGY & THERAPEUTICS
- Rationale and Design of the Strain Surveillance of Chemotherapy for Improving Cardiovascular Outcomes (SUCCOUR) Trial
- (2018) Tomoko Negishi et al. JACC-Cardiovascular Imaging
- 2018 ESC/ESH Guidelines for the management of arterial hypertension
- (2018) Bryan Williams et al. EUROPEAN HEART JOURNAL
- Cardiovascular adverse events in modern myeloma therapy – Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)
- (2018) Sara Bringhen et al. HAEMATOLOGICA
- Toxicity of cancer therapy: what the cardiologist needs to know about angiogenesis inhibitors
- (2018) Stephen J H Dobbin et al. HEART
- Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
- (2018) Joe-Elie Salem et al. LANCET ONCOLOGY
- Cardiovascular Complications of Cancer Therapy
- (2017) Hui-Ming Chang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Risk of Arterial Thromboembolism in Patients With Cancer
- (2017) Babak B. Navi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiac Outcomes in Adult Survivors of Childhood Cancer Exposed to Cardiotoxic Therapy
- (2016) Daniel A. Mulrooney et al. ANNALS OF INTERNAL MEDICINE
- Vascular Complications of Cancer Chemotherapy
- (2016) Alan C. Cameron et al. CANADIAN JOURNAL OF CARDIOLOGY
- Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy
- (2016) Sean A. Virani et al. CANADIAN JOURNAL OF CARDIOLOGY
- Ibrutinib Dosing Strategies Based on Interaction Potential of CYP3A4 Perpetrators Using Physiologically Based Pharmacokinetic Modeling
- (2016) L de Zwart et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- QT interval variability in body surface ECG: measurement, physiological basis, and clinical value: position statement and consensus guidance endorsed by the European Heart Rhythm Association jointly with the ESC Working Group on Cardiac Cellular Electrophysiology
- (2016) Mathias Baumert et al. EUROPACE
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN HEART JOURNAL
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. EUROPEAN HEART JOURNAL
- Management and research in cancer treatment-related cardiovascular toxicity: Challenges and perspectives
- (2016) Jennifer Cautela et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Toxic Effects of Targeted Cancer Therapies
- (2016) Javid J. Moslehi NEW ENGLAND JOURNAL OF MEDICINE
- Tyrosine Kinase Inhibitor–Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia
- (2015) Javid J. Moslehi et al. JOURNAL OF CLINICAL ONCOLOGY
- Vascular and Metabolic Implications of Novel Targeted Cancer Therapies
- (2015) Weijuan Li et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Health of Patients With Cancer and Cancer Survivors
- (2015) Ana Barac et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
- (2014) J. C. Plana et al. European Heart Journal-Cardiovascular Imaging
- Modifiable Risk Factors and Major Cardiac Events Among Adult Survivors of Childhood Cancer
- (2013) Gregory T. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer survival: global surveillance will stimulate health policy and improve equity
- (2013) Michel P Coleman LANCET
- Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib
- (2013) T D Kim et al. LEUKEMIA
- Late Cardiac Effects of Cancer Treatment
- (2012) Daniel J. Lenihan et al. JOURNAL OF CLINICAL ONCOLOGY
- Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML
- (2011) Karl J. Aichberger et al. AMERICAN JOURNAL OF HEMATOLOGY
- The Utility of Cardiac Biomarkers, Tissue Velocity and Strain Imaging, and Cardiac Magnetic Resonance Imaging in Predicting Early Left Ventricular Dysfunction in Patients With Human Epidermal Growth Factor Receptor II–Positive Breast Cancer Treated With Adjuvant Trastuzumab Therapy
- (2011) Nazanin Fallah-Rad et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of Comorbidity on Chemotherapy Use and Outcomes in Solid Tumors: A Systematic Review
- (2010) Linda Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevention of Torsade de Pointes in Hospital Settings
- (2010) Barbara J. Drew et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search